CLOV vs VIVS · rev $1.37B vs P/E 0.7, rev $144.0K
Clover Health Investments Corp (CLOV) versus VivoSim Labs, Inc. (VIVS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VIVS revenue for 2025-03-31 was $144.0K. Net income was -$2.5M. Revenue was up 32.1% from 2024-03-31 to 2025-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
CLOV currently screens at market cap $1.55B. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
Not investment advice. Open the CLOV and VIVS stock pages for the full models.
Not investment advice.